Trueblood Wealth Management’s Lockheed Martin LMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$640K Buy
1,256
+2
+0.2% +$1.08K 0.22% 130
2026
Q1
$758K Buy
1,254
+29
+2% +$17.9K 0.3% 108
2025
Q4
$593K Sell
1,225
-109
-8% -$52.2K 0.23% 133
2025
Q3
$666K Sell
1,334
-137
-9% -$62.2K 0.26% 120
2025
Q2
$681K Buy
1,471
+54
+4% +$25.3K 0.28% 115
2025
Q1
$633K Sell
1,417
-12
-0.8% -$5.52K 0.29% 117
2024
Q4
$694K Hold
1,429
0.34% 99
2024
Q3
$835K Sell
1,429
-8
-0.6% -$4.29K 0.42% 78
2024
Q2
$671K Sell
1,437
-22
-2% -$10.2K 0.38% 84
2024
Q1
$664K Buy
1,459
+63
+5% +$27.6K 0.38% 87
2023
Q4
$633K Buy
+1,396
New +$618K 0.4% 83

Other funds holding LMT

Trueblood Wealth Management's LMT Position: Q2 2026 in Review

Trueblood Wealth Management increased its Lockheed Martin (LMT) stake by 0.16% in Q2 2026, buying an estimated $1.08K and bringing the position to 1,256 shares worth $640K. The position accounts for 0.22% of the portfolio, ranked #130.

Trueblood Wealth Management first reported a position in LMT in Q4 2023 and has held it in 11 quarters since. The position peaked at $835K in Q3 2024. 1,088 funds tracked by Wall St. Rank hold LMT as of Q2 2026.

  • Trueblood Wealth Management held 1,256 shares of Lockheed Martin worth $640K as of Q2 2026.
  • Trueblood Wealth Management bought 2 Lockheed Martin shares in Q2 2026, an estimated $1.08K.
  • Lockheed Martin made up 0.22% of Trueblood Wealth Management's portfolio in Q2 2026, its #130 holding.
  • Trueblood Wealth Management first reported a position in Lockheed Martin in Q4 2023 and has held it in 11 quarters since.
  • Trueblood Wealth Management's Lockheed Martin position peaked at $835K in Q3 2024.
  • 1,088 funds tracked by Wall St. Rank held Lockheed Martin as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.